Stellar Biotechnologies' Reverse Merger Round

Stellar Biotechnologies raised a round of funding on April 15, 2010. Investors include CAG Capital.

Stellar Biotechnologies (NASDAQ: SBOT) specializes in Keyhole Limpet Hemocyanin (KLH) protein and is focused in the rapidly-evolving field of immunotherapy. KLH is an important immune-stimulating mole…

Articles about Stellar Biotechnologies' Reverse Merger Round: